PRIME MEDICINE INC(NASDAQ:PRME) stock News

PRME Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Prime Medicine, Inc.

Prime Medicine to Participate in Upcoming Investor Conferences

23 days ago - By: Benzinga - Mentions: ILMN VRTX LLY NVO ...

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years

a month ago - By: Benzinga - Mentions: RZLV YDES URG ALKS ...

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday

2 months ago - By: The Motley Fool - Mentions: BMY

PRME Revenue Misses by 73%

2 months ago - By: Prime Medicine, Inc.

Prime Medicine to Participate in Upcoming Investor Conferences

2 months ago - By: Zacks Investment Research - Mentions: TELA

Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Pricing of Public Offering

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Pricing of Public Offering

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Proposed Public Offering of Common Stock

2 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Proposed Public Offering of Common Stock

3 months ago - By: Yahoo Finance - Mentions: MS SCHW IR

BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT

3 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

3 months ago - By: Prime Medicine, Inc.

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

5 months ago - By: Prime Medicine, Inc.

Prime Medicine to Participate in Upcoming Investor Conferences

5 months ago - By: Prime Medicine, Inc.

Prime Medicine to Participate in Upcoming Investor Conferences

5 months ago - By: Yahoo Finance - Mentions: INFY NXT TGT AAPL

Infosys and E.ON Join Forces to Develop AI-Powered Digital Workplaces

5 months ago - By: Yahoo Finance - Mentions: NXT IBTA NI HMY ...

Nextracker Expands in India After Surpassing 10 GW Milestone

5 months ago - By: Yahoo Finance - Mentions: DLO GME MSTR HMY ...

Citi Initiates Coverage of DLocal (DLO) with a Buy Rating

5 months ago - By: Yahoo Finance - Mentions: EHC NVDA NPCE KZR ...

Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty

5 months ago - By: Yahoo Finance - Mentions: HMY MTAL MEC LLY ...

PRIME MEDICINE INC (PRME) Stock News

PRME Latest News, Press Relases and Analysis

Prime Medicine to Participate in Upcoming Investor Conferences

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday

PRME Revenue Misses by 73%

Prime Medicine to Participate in Upcoming Investor Conferences

Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Prime Medicine Announces Pricing of Public Offering

Prime Medicine Announces Pricing of Public Offering

Prime Medicine Announces Proposed Public Offering of Common Stock

Prime Medicine Announces Proposed Public Offering of Common Stock

BMO Capital Maintains a Buy on Prime Medicine (PRME), Sets a $10 PT

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Prime Medicine to Participate in Upcoming Investor Conferences

Prime Medicine to Participate in Upcoming Investor Conferences

Infosys and E.ON Join Forces to Develop AI-Powered Digital Workplaces

Nextracker Expands in India After Surpassing 10 GW Milestone

Citi Initiates Coverage of DLocal (DLO) with a Buy Rating

Citi Downgrades Prime Medicine (PRME) to Neutral, Cuts PT to $1.50 Due to Market Uncertainty

Harmony Gold to Acquire MAC Copper in $1.03 Billion Deal, Boosting Copper Exposure